ACKR3 has been reported as a potential therapeutic target for peripheral tissue disease such as cancer, cardiovascular diseases, and inflammatory processes [61–63] and the Ackr3-Venus KI mouse generated here will be instrumental in the ongoing research efforts to understand ACKR3 signaling in peripheral tissues [64] and contributions to disease. This evidence concerns the gene ACKR3 and cardiovascular disorder.